Feasibility of clinical pharmacist-led CYP2C19 genotyping for patients receiving non-emergent cardiac catheterization in an integrated health system

Objective: To assess the feasibility of clinical pharmacist-led CYP2C19 genotype-guided P2Y12 inhibitor antiplatelet drug therapy recommendations to cardiologists in an outpatient cardiology practice. Methods: This was a prospective, open-labeled, single-arm study conducted in an integrated healthca...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Johnson SG (Autor), Shaw PB (Autor), Delate T (Autor), Kurz DL (Autor), Gregg D (Autor), Darnell JC (Autor), Aquilante CL (Autor)
Format: Knjiga
Izdano: Centro de Investigaciones y Publicaciones Farmaceuticas, 2017-06-01T00:00:00Z.
Teme:
Online pristup:Connect to this object online.
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Internet

Connect to this object online.

3rd Floor Main Library

Detalji primjeraka od 3rd Floor Main Library
Signatura: A1234.567
Primjerak 1 Dostupno